Artikel
Lizenziert
Nicht lizenziert
Erfordert eine Authentifizierung
Titelei
Veröffentlicht/Copyright:
21. Oktober 2009
Published Online: 2009-10-21
Published in Print: 1993
Walter de Gruyter
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Sie haben derzeit keinen Zugang zu diesem Inhalt.
Artikel in diesem Heft
- Titelei
- Sonstiges
- Carry-Over Biases in Clinical Pharmacology
- Alkaline Phosphatase in Human Semen: An Investigation Using Enzyme Inhibitors and Gel Electrophoresis
- Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms
- Laboratory Assessment of Five Glucose Meters Designed for Self-Monitoring of Blood Glucose Concentration
- Complex Analyte-Dependent and Analyte-Independent Interferences with Conjugated Bilirubin in the Enzymatic Phenol-Aminophenazone Peroxidase (PAP) Method for Creatinine Determination
- A European Quality Control Programme as a Cooperative Tool between Users and a Diagnostic Company
- Automated Enzymatic Methods for Creatinine Measurement with Special Attention to Bilirubin Interference
- TECHNICAL NOTE
- Technical Reports
- Acknowledgement
Artikel in diesem Heft
- Titelei
- Sonstiges
- Carry-Over Biases in Clinical Pharmacology
- Alkaline Phosphatase in Human Semen: An Investigation Using Enzyme Inhibitors and Gel Electrophoresis
- Prolactin Heterogeneity: A Limitation on the Evaluation of Results from Prolactin Assays due to Differences in Immunoassays and the Different Bioactivities of Prolactin Forms
- Laboratory Assessment of Five Glucose Meters Designed for Self-Monitoring of Blood Glucose Concentration
- Complex Analyte-Dependent and Analyte-Independent Interferences with Conjugated Bilirubin in the Enzymatic Phenol-Aminophenazone Peroxidase (PAP) Method for Creatinine Determination
- A European Quality Control Programme as a Cooperative Tool between Users and a Diagnostic Company
- Automated Enzymatic Methods for Creatinine Measurement with Special Attention to Bilirubin Interference
- TECHNICAL NOTE
- Technical Reports
- Acknowledgement